Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency

Jeffrey H Ringrose1, Rienk E Jeeninga, Ben Berkhout

  • 1K1-262, Academic Medical Center, University of Amsterdam, Clinical Proteomics Group, Medical Biochemistry, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. d.speijer@amc.uva.nl

Journal of Virology
|February 22, 2008
PubMed

Insights

Human immunodeficiency virus type 1 (HIV-1) infection alters T cell protein levels, causing metabolic shifts and influencing apoptosis and transport proteins. This proteomic study reveals key cellular changes during HIV infection.

Area of Science:

  • Proteomics
  • Immunology
  • Virology

Background:

  • Human immunodeficiency virus type 1 (HIV-1) infection significantly impacts host cell biology.
  • Understanding cellular changes in T cells is crucial for HIV-1 pathogenesis research.

Purpose of the Study:

  • To comprehensively analyze proteomic alterations in human T cells following HIV-1 infection.
  • To identify specific proteins and pathways affected by HIV-1 at the cellular level.

Main Methods:

  • Two-dimensional differential in-gel electrophoresis proteomic analysis.
  • Identification and quantification of differentially expressed proteins in infected T cells.

Main Results:

  • 15% of 2,000 detected protein spots showed differential expression at peak HIV-1 infection.
  • 93 proteins were identified with altered abundance; 27 downregulated and 66 upregulated.
  • Significant metabolic rerouting observed: downregulated glycolysis and enhanced mitochondrial oxidation.
  • Proteins involved in apoptotic signaling and intracellular transport were notably affected.

Conclusions:

  • HIV-1 infection induces widespread proteomic changes in T cells.
  • Metabolic reprogramming, apoptosis modulation, and altered intracellular transport are key cellular responses to HIV-1.
  • These findings provide insights into HIV-1's impact on cellular functions and potential therapeutic targets.